摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1-羟基-1-磷)十六基磷酸 | 2809-24-7

中文名称
(1-羟基-1-磷)十六基磷酸
中文别名
——
英文名称
(1-hydroxyhexadecane-1,1-diyl)diphosphonic acid
英文别名
hexadecyl-1-hydroxy-1,1-bisphosphonate;(1-Hydroxy-1-phosphonohexadecyl)phosphonic acid
(1-羟基-1-磷)十六基磷酸化学式
CAS
2809-24-7
化学式
C16H36O7P2
mdl
——
分子量
402.405
InChiKey
CRTLLTFVYOUDFN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    25
  • 可旋转键数:
    16
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    135
  • 氢给体数:
    5
  • 氢受体数:
    7

SDS

SDS:0e7e77cfe65e0bfb74ffd003301eed62
查看

反应信息

  • 作为反应物:
    描述:
    (1-羟基-1-磷)十六基磷酸β-环糊精 以 aq. phosphate buffer 为溶剂, 生成
    参考文献:
    名称:
    Cyclodextrins: A promising drug delivery vehicle for bisphosphonate
    摘要:
    Bisphosphonates are well established pharmaceutical drugs with wide applications in medicine. Nevertheless, the side chain and the nature of phosphorous groups could induce a poor aqueous solubility and act on their bioavailability. At the same time, cyclodextrins are cage molecules that facilitate transport of hydrophobic molecules to enhance the intestinal drug absorption of these molecules by forming inclusion complexes.Here we demonstrate that cyclodextrins could be used as a bisphosphonate carrier. The formation of cyclodextrins-bisphosphonate complexes was characterized by 1D and 2D NMR spectroscopy, Isothermal Titration Calorimetry and UV-vis spectroscopy. The results revealed that only the side chain of bisphosphonate was involved in the inclusion phenomenon and its length was a crucial parameter in the control of affinity. Findings from this study suggest that cyclodextrin will be a useful carrier for bisphosphonates. (C) 2016 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.carbpol.2016.09.030
  • 作为产物:
    描述:
    甲醇 作用下, 生成 (1-羟基-1-磷)十六基磷酸
    参考文献:
    名称:
    Effects of Bisphosphonates on the Growth of Entamoeba histolytica and Plasmodium Species in Vitro and in Vivo
    摘要:
    The effects of a series of 102 bisphosphonates on the inhibition of growth of Entamoeba histolytica and Plasmodium falciparum in vitro have been determined, and selected compounds were further investigated for their in vivo activity. Forty-seven compounds tested were active (IC50 < 200 muM) versus E. histolytica growth in vitro. The most active compounds (IC50 similar to 4-9 muM) were nitrogen-containing bisphosphonates with relatively large aromatic side chains. Simple n-alkyl-1-hydroxy-1,1-bisphosphonates, known inhibitors of the enzyme farnesylpyrophosphate (FPP) synthase, were also active, with optimal activity being found with C9-C10 side chains. However, numerous other nitrogen-containing bisphosphonates known to be potent FPP synthase inhibitors, such as risedronate or pamidronate, had little or no activity. Several pyridine-derived bisphosphonates were quite active (IC50 similar to 10-20 muM), and this activity was shown to correlate with the basicity of the aromatic group, with activity decreasing with increasing pK(a) values. The activities of all compounds were tested versus a human nasopharyngeal carcinoma (KB) cell line to enable an estimate of the therapeutic index (TI). Five bisphosphonates were selected and then screened for their ability to delay the development of amebic liver abscess formation in an E. histolytica infected hamster model. Two compounds were found to decrease liver abscess formation at 10 mg/kg ip with little or no effect on normal liver mass. With P. falciparum, 35 compounds had IC50 values <200 muM in an in vitro assay. The most active compounds were also simple n-alkyl-1-hydroxy-1,1-bisphosphonates, having IC50 values around 1 muM. Five compounds were again selected for in vivo investigation in a Plasmodium berghei ANKA BALB/c mouse suppressive test. The most active compound, a C9 n-alkyl side chain containing bisphosphonate, caused an 80% reduction in parasitemia with no overt toxicity. Taken together, these results show that bisphosphonates appear to be useful lead compounds for the development of novel antiamebic and antimalarial drugs.
    DOI:
    10.1021/jm030084x
点击查看最新优质反应信息

文献信息

  • 3-D QSAR Investigations of the Inhibition of <i>Leishmania </i><i>m</i><i>ajor</i> Farnesyl Pyrophosphate Synthase by Bisphosphonates
    作者:John M. Sanders、Aurora Ortiz Gómez、Junhong Mao、Gary A. Meints、Erin M. Van Brussel、Agnieszka Burzynska、Pawel Kafarski、Dolores González-Pacanowska、Eric Oldfield
    DOI:10.1021/jm0302344
    日期:2003.11.1
    set results (N = 62 compounds) yielded good correlations with each technique (R(2) = 0.87 and 0.88, respectively), and were further validated by using a training/test set approach. Test set results (N = 24 compounds) indicated that IC(50) values could be predicted within factors of 2.9 and 2.7 for the CoMFA and CoMSIA methods, respectively. The CoMSIA fields indicated that a positive charge in the bisphosphonate
    我们报告了作为利什曼原虫主要甲羟戊酸/异戊二烯生物合成途径酶,法呢基焦磷酸合酶的抑制剂的62二膦酸盐的活性。所研究的化合物具有约100 nM至约80 microM(相当于K(i)值低至10 nM)的活性(IC(50)值)。发现活性最高的化合物是唑来膦酸盐(据报道其单晶X射线结构),吡啶基-乙烷-1-羟基-1,1-双膦酸酯或吡啶甲基氨基亚甲基双膦酸酯。但是,N-脂环族氨基亚甲基双膦酸酯(如茚满膦酸酯)(N-环庚基氨基亚甲基双膦酸酯)以及含有短(n = 4、5)烷基链的脂族氨基亚甲基双膦酸酯也具有活性,IC(50)值在200-1700 nM范围内(对应于大约20-170 nM的K(i)值)。含有更长或多个(N,N-)烷基取代基的双膦酸酯是无活性的,环上缺少邻或间氮原子或具有多个卤素取代基或对氨基的芳香族化合物也是如此。为了将这些观察结果放在更定量的结构基础上,我们使用了三维定量结构-活性关系技
  • Electrically conductive coating composition
    申请人:LION CORPORATION
    公开号:EP0292190A2
    公开(公告)日:1988-11-23
    An electrically conductive coating composition containing a metallic powder, a thermoplastic and/or thermosetting resin, and a diphosphonic acid derivative having the formula (I): wherein R represents an alkyl having 3 to 21 carbon atoms or an aryl having 6 to 14 carbon atoms and M¹ to M⁴ independently represent hydrogen or a cation.
    一种导电涂料组合物,含有金属粉末、热塑性和/或热固性树脂以及具有式 (I) 的二膦酸衍生物: 其中 R 代表具有 3 至 21 个碳原子的烷基或具有 6 至 14 个碳原子的芳基,M¹ 至 M⁴ 独立地代表氢或阳离子。
  • Schuelke, Ulrich, Phosphorus, Sulfur and Silicon and the Related Elements, 1990, vol. 51/52, p. 623 - 626
    作者:Schuelke, Ulrich
    DOI:——
    日期:——
  • JPH02185574A
    申请人:——
    公开号:JPH02185574A
    公开(公告)日:1990-07-19
  • US4020091A
    申请人:——
    公开号:US4020091A
    公开(公告)日:1977-04-26
查看更多

同类化合物

(1-氨基丁基)磷酸 顺丙烯基磷酸 除草剂BUMINAFOS 阿仑膦酸 阻燃剂 FRC-1 铵甲基膦酸盐 钠甲基乙酰基膦酸酯 钆1,5,9-三氮杂环十二烷-N,N',N''-三(亚甲基膦酸) 钆-1,4,7-三氮杂环壬烷-N,N',N''-三(亚甲基膦酸) 重氮甲基膦酸二乙酯 辛基膦酸二丁酯 辛基膦酸 辛基-膦酸二钾盐 辛-1-烯-2-基膦酸 试剂12-Azidododecylphosphonicacid 英卡膦酸 苯胺,4-乙烯基-2-(1-甲基乙基)- 苯甲基膦酸二甲酯 苯基膦酸二甲酯 苯基膦酸二仲丁酯 苯基膦酸二乙酯 苯基膦酸二乙酯 苯基磷酸二辛酯 苯基二异辛基亚磷酸酯 苯基(1H-1,2,4-三唑-1-基)甲基膦酸二乙酯 苯丁酸,b-氨基-g-苯基- 苄基膦酸苄基乙酯 苄基亚甲基二膦酸 膦酸,[(2-乙基己基)亚氨基二(亚甲基)]二,triammonium盐(9CI) 膦酸叔丁酯乙酯 膦酸单十八烷基酯钾盐 膦酸二辛酯 膦酸二(二十一烷基)酯 膦酸,辛基-,单乙基酯 膦酸,甲基-,单(2-乙基己基)酯 膦酸,甲基-,二(苯基甲基)酯 膦酸,甲基-,2-甲氧基乙基1-甲基乙基酯 膦酸,丁基乙基酯 膦酸,[苯基[(苯基甲基)氨基]甲基]-,二甲基酯 膦酸,[[羟基(苯基甲基)氨基]苯基甲基]-,二(苯基甲基)酯 膦酸,[2-(环丙基氨基)-2-羰基乙基]-,二乙基酯 膦酸,[2-(二甲基亚肼基)丙基]-,二乙基酯,(E)- 膦酸,[1-甲基-2-(苯亚氨基)乙烯基]-,二乙基酯 膦酸,[1-(乙酰基氨基)-1-甲基乙基]-(9CI) 膦酸,[(环己基氨基)苯基甲基]-,二乙基酯 膦酸,[(二乙氧基硫膦基)(二甲氨基)甲基]- 膦酸,[(2S)-2-氨基-2-苯基乙基]-,二乙基酯 膦酸,[(1Z)-2-氨基-2-(2-噻嗯基)乙烯基]-,二乙基酯 膦酸,P-[(二乙胺基)羰基]-,二乙基酯 膦酸,(氨基二环丙基甲基)-